Department of Pediatrics, Saint Vincent de Paul-French Hospital, Nazareth, Israel.
Department of Epidemiology and Preventive Medicine, School of Public Health, Sackler Faculty of Medicine, Tel Aviv University Ramat Aviv, Tel Aviv, Israel.
Pediatr Pulmonol. 2020 Sep;55(9):2236-2245. doi: 10.1002/ppul.24905. Epub 2020 Jul 7.
Controversy exists regarding an association between Helicobacter pylori infection and asthma in children. We examined the hypotheses of inverse associations of H. pylori seroprevalence and pepsinogen (PG) levels, as markers of gastric inflammation, with asthma in children.
A hospital-based case-control study was conducted among children aged 4.8 to 17.3 years in Israel. Confirmed asthma cases (n = 75) were recruited through a pulmonary clinic, and controls (n = 160) without asthma were enrolled. Using enzyme-linked immunosorbent assays we measured the presence of H. pylori immunoglobulin G (IgG) antibodies, IgG antibodies to cytotoxin-associated gene A antigen (CagA) (virulent factor), serum PG levels and exposure to other enteric pathogens (Shigella flexneri). Multivariable logistic regression models were applied.
H. pylori IgG seropositivity was 25% and 40% among cases and controls, respectively (P = .03). H. pylori CagA IgG seropositivity was associated with reduced risk of asthma (adjusted odds ratio [OR], 0.33 [95% CI, 0.11-0.95] but not for the CagA negative serology (adjusted OR, 0.70 [95% CI, 0.32-1.54]). Children who were H. pylori seropositive with a PGI:PGII of ≤6.78 (severe gastric inflammation) had a lower likelihood of asthma (adjusted OR, 0.31 [95% CI, 0.10-0.89]) than did seronegative children. Exposure to Shigella flexneri did not differ between cases and controls, nor according to H. pylori seropositivity. Among the asthmatic children, pulmonary function did not differ according to H. pylori seropositivity.
H. pylori infection and its related gastric inflammation may have a protective role in the risk of pediatric asthma and further research into a potential causal pathway is required.
关于儿童幽门螺杆菌(H. pylori)感染与哮喘之间的关联,存在争议。我们检验了 H. pylori 血清阳性率和胃蛋白酶原(PG)水平(胃炎症的标志物)与儿童哮喘呈负相关的假说。
在以色列,我们开展了一项基于医院的病例对照研究,纳入了 4.8 岁至 17.3 岁的儿童。通过肺病门诊招募确诊哮喘病例(n=75),并招募无哮喘的对照(n=160)。我们使用酶联免疫吸附测定法检测 H. pylori 免疫球蛋白 G(IgG)抗体、细胞毒素相关基因 A 抗原(CagA)(毒力因子)IgG 抗体、血清 PG 水平和其他肠道病原体(福氏志贺菌)的暴露情况。应用多变量逻辑回归模型。
病例组和对照组的 H. pylori IgG 血清阳性率分别为 25%和 40%(P=0.03)。H. pylori CagA IgG 血清阳性与哮喘风险降低相关(校正比值比[OR],0.33[95%置信区间,0.11-0.95]),但 CagA 阴性血清学结果无此关联(校正 OR,0.70[95%置信区间,0.32-1.54])。PGI:PGII 比值≤6.78(严重胃炎症)的 H. pylori 血清阳性儿童患哮喘的可能性较低(校正 OR,0.31[95%置信区间,0.10-0.89]),而血清阴性儿童则不然。病例组和对照组之间、H. pylori 血清阳性与阴性儿童之间的福氏志贺菌暴露情况并无差异。在哮喘儿童中,肺功能也与 H. pylori 血清阳性无关。
H. pylori 感染及其相关胃炎症可能对儿童哮喘风险具有保护作用,需要进一步研究潜在的因果途径。